SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-21-035856
Filing Date
2021-03-15
Accepted
2021-03-15 06:33:20
Documents
2
Group Members
ALEC N. LITOWITZMAGNETAR CAPITAL PARTNERS LPSUPERNOVA MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D tm219479d1_sc13d.htm SC 13D 92952
2 EXHIBIT 99.1 tm219479d1_ex99-1.htm EX-99.1 8138
  Complete submission text file 0001104659-21-035856.txt   102823
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS, INC. (Subject) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87623 | Film No.: 21739732
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1603 ORRINGTON AVE. 13TH FLOOR EVANSTON IL 60201
Business Address 1603 ORRINGTON AVE. 13TH FLOOR EVANSTON IL 60201 (847)905-4400
Magnetar Financial LLC (Filed by) CIK: 0001352851 (see all company filings)

IRS No.: 043818748 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D